BioMelbourne Network is now in the process of implementing a three-year strategy, developed through significant engagement and interaction with our members, local and national industry bodies, and the State Government of Victoria. Click here to view the BioMelbourne…
This Masterclass Series is sponsored by the State Government of Victoria, Department of Jobs, Precincts and Regions. The success of early-stage biopharma hinges not only on the efficacy and safety of a product, but on the company’s ability…
19 September In the US, the shift in where care is rendered is practically seismic. Almost overnight it seems (5 years in real world terms), retail clinics have become an important part of primary care and convenience is…
17 September 2019 When the Australian Regenerative Medicine Institute at Monash University needed help to boost industry awareness of its work and interact with the growing regenerative medicine sector, the BioMelbourne Network helped with contacts and hosted a…
16 September 2019 Our industry is under attack – there is no doubt about it! The news of yet another organization falling victim to cybercrime has become a daily occurrence. As long as there is a promise of…
12 August 2019 Right now, as you’re reading this, lightning-fast instructions are racing through the fibres of your brain. Regulating your breathing. Keeping your core temperature stable. Comprehending the words on the page. There are thousands of these…
(posted 6th August 2019) Stephens Lawyers & Consultants have published an article which includes practical guidelines on steps that can be taken by businesses/companies to ensure that their AI generated works are protected by copyright. This is the…
June 2019 The Independent Hospital Pricing Authority (IHPA) has released its Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2020-21. Read more
12 June 2019 Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been there: Eli Lilly, ICI Australia, CSL Limited,…
ASX 200 boards have made substantial progress since 2009 when the percentage of female directors stood at just 8.3%. It now stands at 27.7%. The Australian Institute of…
Our vision for Victoria is to lead the world in health innovation. Discovering, developing and manufacturing the health technologies that change the world. New drugs, devices, diagnostics, vaccines, therapies and digital products – Victoria is the best place to…